{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T23:01:31Z","timestamp":1780009291462,"version":"3.53.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA055695"],"award-info":[{"award-number":["K23DA055695"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s11606-025-09635-y","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T10:10:50Z","timestamp":1748513450000},"page":"3481-3485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Initiating Medications for Opioid Use Disorder in Hospitalized Incarcerated Patients"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8006-8675","authenticated-orcid":false,"given":"Lawrence A.","family":"Haber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Taub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"South","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"9635_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2022.100052","volume":"3","author":"KM Keyes","year":"2022","unstructured":"Keyes KM, Rutherford C, Hamilton A, Barocas JA, Gelberg KH, Mueller PP, Feaster DJ, El-Bassel N, Cerd\u00e1 M. What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size. Drug Alcohol Depend Rep. 2022;3:100052. https:\/\/doi.org\/10.1016\/j.dadr.2022.100052.","journal-title":"Drug Alcohol Depend Rep."},{"key":"9635_CR2","unstructured":"Gramlich J. Recent surge in U.S. drug overdose deaths has hit Black men the hardest. Pew Research Center. https:\/\/www.pewresearch.org\/short-reads\/2022\/01\/19\/recent-surge-in-u-s-drug-overdose-deaths-has-hit-black-men-the-hardest\/ Accessed August 1, 2024."},{"key":"9635_CR3","doi-asserted-by":"publisher","unstructured":"Dowell D, Brown S, Gyawali S, et al. Treatment for Opioid Use Disorder: Population Estimates \u2014 United States, 2022. MMWR Morb Mortal Wkly Rep 2024;73:567\u2013574. https:\/\/doi.org\/10.15585\/mmwr.mm7325a1.","DOI":"10.15585\/mmwr.mm7325a1"},{"key":"9635_CR4","doi-asserted-by":"publisher","unstructured":"Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerd\u00e1 M. Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019\". Int J Drug Policy. 2022;110:103786. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103786.","DOI":"10.1016\/j.drugpo.2022.103786"},{"issue":"8","key":"9635_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMp2204687","volume":"387","author":"H Englander","year":"2022","unstructured":"Englander H, Davis CS. Hospital Standards of Care for People with Substance Use Disorder. N Engl J Med. 2022;387(8):672-675. https:\/\/doi.org\/10.1056\/NEJMp2204687.","journal-title":"N Engl J Med."},{"key":"9635_CR6","doi-asserted-by":"crossref","unstructured":"Brown, AM, et al. National hospital care survey demonstration projects: characteristics and mortality outcomes of opioid-involved hospital encounters with co-occurring disorders. National Health Statistics Reports. Number 173. July 25, 2022.","DOI":"10.15620\/cdc:118082"},{"issue":"2","key":"9635_CR7","doi-asserted-by":"publisher","first-page":"e2356382","DOI":"10.1001\/jamanetworkopen.2023.56382","volume":"7","author":"M Martin","year":"2024","unstructured":"Martin M, Krawczyk N. Linking Hospitalized Patients With Opioid Use Disorder to Treatment-The Importance of Care Transitions. JAMA Netw Open. 2024;7(2):e2356382. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.56382.","journal-title":"JAMA Netw Open."},{"key":"9635_CR8","unstructured":"Sawyer W, Wagner P. Mass Incarceration: The Whole Pie 2024. Prison Policy Initiative. March 14, 2024. https:\/\/www.prisonpolicy.org\/reports\/pie2024.html Accessed August 1, 2024."},{"issue":"44","key":"9635_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev-publhealth-071521-034016","volume":"3","author":"DH Cloud","year":"2023","unstructured":"Cloud DH, Garcia-Grossman IR, Armstrong A, Williams B. Public Health and Prisons: Priorities in the Age of Mass Incarceration. Annu Rev Public Health. 2023;44:407-428. https:\/\/doi.org\/10.1146\/annurev-publhealth-071521-034016.","journal-title":"Annu Rev Public Health."},{"key":"9635_CR10","unstructured":"Bronson J, Stroop J, Zimmer S, Berzofsky M. Drug use, dependence, and abuse among state prisoners and jail inmates, 2007\u20132009. Washington, DC: United States Department of Justice, Office of Juvenile Justice and Delinquency Prevention. 2017."},{"issue":"3","key":"9635_CR11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2105\/AJPH.2012.301148","volume":"103","author":"EJ Patterson","year":"2013","unstructured":"Patterson EJ. The dose-response of time served in prison on mortality: New York State, 1989-2003. Am J Public Health. 2013;103(3):523-8. https:\/\/doi.org\/10.2105\/AJPH.2012.301148.","journal-title":"Am J Public Health."},{"issue":"1","key":"9635_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13722-019-0145-5","volume":"14","author":"PJ Joudrey","year":"2019","unstructured":"Joudrey PJ, Khan MR, Wang EA, Scheidell JD, Edelman EJ, McInnes DK, Fox AD. A conceptual model for understanding post-release opioid-related overdose risk. Addict Sci Clin Pract. 2019;14(1):17. https:\/\/doi.org\/10.1186\/s13722-019-0145-5.","journal-title":"Addict Sci Clin Pract."},{"issue":"4","key":"9635_CR13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/ADM.0000000000000915","volume":"16","author":"C King","year":"2022","unstructured":"King C, Cook R, Korthuis PT, Morris CD, Englander H. Causes of Death in the 12 Months After Hospital Discharge Among Patients With Opioid Use Disorder. J Addict Med. 2022;16(4):466-469. https:\/\/doi.org\/10.1097\/ADM.0000000000000915.","journal-title":"J Addict Med."},{"issue":"1","key":"9635_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40352-023-00209-w","volume":"11","author":"L Cates","year":"2023","unstructured":"Cates L, Brown AR. Medications for opioid use disorder during incarceration and post-release outcomes. Health Justice. 2023;11(1):4. https:\/\/doi.org\/10.1186\/s40352-023-00209-w.","journal-title":"Health Justice."},{"issue":"20","key":"9635_CR15","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1001\/jama.2023.5904","volume":"329","author":"AM South","year":"2023","unstructured":"South AM, Fanucchi L, Lofwall M. Treating Opioid Use Disorder in Patients Who Are Incarcerated: Quandaries of a Hospitalist. JAMA. 2023;329(20):1738-1739. https:\/\/doi.org\/10.1001\/jama.2023.5904.","journal-title":"JAMA."},{"key":"9635_CR16","doi-asserted-by":"publisher","unstructured":"Mooney LJ, Valdez J, Cousins SJ, Yoo C, Zhu Y, Hser YI. Patient decision aid for medication treatment for opioid use disorder (PtDA-MOUD): Rationale, methodology, and preliminary results. J Subst Abuse Treat. 2020;108. https:\/\/doi.org\/10.1016\/j.jsat.2019.08.006","DOI":"10.1016\/j.jsat.2019.08.006"},{"key":"9635_CR17","unstructured":"Medication-assisted Treatment Inside Correctional Facilities: Addressing Medication Diversion. Substance Abuse and Mental Health Services Administration. https:\/\/store.samhsa.gov\/sites\/default\/files\/pep19-mat-corrections.pdf Accessed November 5, 2024."},{"key":"9635_CR18","doi-asserted-by":"publisher","unstructured":"Lee JD, Nunes EV, Novo P, et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. The Lancet. 2018;391(10118). https:\/\/doi.org\/10.1016\/S0140-6736(17)32812-X","DOI":"10.1016\/S0140-6736(17)32812-X"},{"issue":"10","key":"9635_CR19","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2105\/AJPH.2018.304666","volume":"108","author":"JG Clarke","year":"2018","unstructured":"Clarke JG, Martin RA, Gresko SA, Rich JD. The first comprehensive program for opioid use disorder in a us statewide correctional system. Am J Public Health. 2018;108(10):1323-1325. https:\/\/doi.org\/10.2105\/AJPH.2018.304666","journal-title":"Am J Public Health."},{"issue":"10","key":"9635_CR20","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s11606-024-08805-8","volume":"39","author":"AM South","year":"2024","unstructured":"South AM, Haber LA, Berk J. Hospitalization Through the Lens of Incarceration. J Gen Intern Med. 2024;39(10):1905-1909. https:\/\/doi.org\/10.1007\/s11606-024-08805-8.","journal-title":"J Gen Intern Med."},{"issue":"11","key":"9635_CR21","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/jamainternmed.2019.3881","volume":"179","author":"LA Haber","year":"2019","unstructured":"Haber LA, Erickson HP, Ranji SR, Ortiz GM, Pratt LA. Acute Care for Patients Who Are Incarcerated: A Review. JAMA Intern Med. 2019;179(11):1561-1567. https:\/\/doi.org\/10.1001\/jamainternmed.2019.3881.","journal-title":"JAMA Intern Med."},{"issue":"10","key":"9635_CR22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.12788\/jhm.3265","volume":"14","author":"LA Haber","year":"2019","unstructured":"Haber LA, DeFries T, Martin M. Things We Do for No Reason\u2122: Discontinuing Buprenorphine When Treating Acute Pain. J Hosp Med. 2019;14(10):633-635. https:\/\/doi.org\/10.12788\/jhm.3265.","journal-title":"J Hosp Med."},{"issue":"11","key":"9635_CR23","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1111\/add.15030","volume":"115","author":"C Sufrin","year":"2020","unstructured":"Sufrin C, Sutherland L, Beal L, Terplan M, Latkin C, Clarke JG. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study. Addiction. 2020;115(11):2057-2065. https:\/\/doi.org\/10.1111\/add.15030.","journal-title":"Addiction."},{"issue":"1","key":"9635_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ogc.2022.10.015","volume":"50","author":"AR Sanjanwala","year":"2023","unstructured":"Sanjanwala AR, Lim G, Krans EE. Opioids and opioid use disorder in pregnancy. Obstetr Gynecol Clin. 2023;50(1):229-40.","journal-title":"Obstetr Gynecol Clin."},{"issue":"5","key":"9635_CR25","doi-asserted-by":"publisher","first-page":"100106","DOI":"10.1016\/j.dadr.2022.100106","volume":"9","author":"MK Reed","year":"2022","unstructured":"Reed MK, Murali V, Sarpoulaki N, Zavodnick JH, Hom JK, Rising KL. Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder. Drug Alcohol Depend Rep. 2022;5:100106. https:\/\/doi.org\/10.1016\/j.dadr.2022.100106.","journal-title":"Drug Alcohol Depend Rep."},{"issue":"Suppl 3","key":"9635_CR26","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s11606-020-06257-4","volume":"35","author":"K Mackey","year":"2020","unstructured":"Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review. J Gen Intern Med. 2020;35(Suppl 3):954-963. https:\/\/doi.org\/10.1007\/s11606-020-06257-4.","journal-title":"J Gen Intern Med."},{"issue":"2","key":"9635_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11606-020-06510-w","volume":"37","author":"KC Brooks","year":"2022","unstructured":"Brooks KC, Makam AN, Haber LA. Caring for Hospitalized Incarcerated Patients: Physician and Nurse Experience. J Gen Intern Med. 2022;37(2):485-487. https:\/\/doi.org\/10.1007\/s11606-020-06510-w.","journal-title":"J Gen Intern Med."},{"issue":"4","key":"9635_CR28","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s11606-024-09136-4","volume":"40","author":"S Nepal","year":"2025","unstructured":"Nepal S, Haber LA, Stella SA. Decoding Homelessness: Z-Codes and the Recognition of Homelessness as a Comorbid Condition. J Gen Intern Med. 2025;40(4):922-926. https:\/\/doi.org\/10.1007\/s11606-024-09136-4.","journal-title":"J Gen Intern Med."},{"issue":"3","key":"9635_CR29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.annemergmed.2021.04.023","volume":"78","author":"K Hawk","year":"2021","unstructured":"Hawk K, Hoppe J, Ketcham E, LaPietra A, Moulin A, Nelson L, Schwarz E, Shahid S, Stader D, Wilson MP, D'Onofrio G. Consensus Recommendations on the Treatment of Opioid Use Disorder in the Emergency Department. Ann Emerg Med. 2021;78(3):434-442. https:\/\/doi.org\/10.1016\/j.annemergmed.2021.04.023.","journal-title":"Ann Emerg Med."},{"key":"9635_CR30","doi-asserted-by":"crossref","unstructured":"Martin M, Calcaterra S. Improving Care for Hospitalized Patients with Opioid Use Disorder: Implementation Guide. Society of Hospital Medicine. Opioid Response Network. https:\/\/www.hospitalmedicine.org\/globalassets\/clinical-topics\/clinical-pdf\/oud-implementation-guide.pdf Accessed April 7, 2025.","DOI":"10.1001\/jamainternmed.2025.0001"},{"key":"9635_CR31","doi-asserted-by":"publisher","unstructured":"Ober AJ,\u00a0Murray-Krezan C,\u00a0Page K, et al. Hospital Addiction Consultation Service and Opioid Use Disorder Treatment:\u00a0The START Randomized Clinical Trial.\u00a0JAMA Intern Med.\u00a0Published online April 07, 2025. https:\/\/doi.org\/10.1001\/jamainternmed.2024.8586","DOI":"10.1001\/jamainternmed.2024.8586"},{"key":"9635_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.drugalcdep.2017.11.023","volume":"184","author":"L Brinkley-Rubinstein","year":"2018","unstructured":"Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, Rich J. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug Alcohol Depend. 2018;184:57-63. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.11.023.","journal-title":"Drug Alcohol Depend."},{"key":"9635_CR33","unstructured":"Justice Department Issues Guidance on Protections for People with Opioid Use Disorder under the Americans with Disabilities Act. US Department of Justice. Tuesday, April 5, 2022. https:\/\/www.justice.gov\/opa\/pr\/justice-department-issues-guidance-protections-people-opioid-use-disorder-under-americans. Accessed August 21, 2024."},{"issue":"4","key":"9635_CR34","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/ADM.0000000000000942","volume":"16","author":"J Berk","year":"2022","unstructured":"Berk J, Del Pozo B, Rich JD, Lee JD. Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting. J Addict Med. 2022;16(4):396-398.","journal-title":"J Addict Med."},{"key":"9635_CR35","unstructured":"Rising J, Whaley S, Saloner B. How the Drug Enforcement Administration Can Improve Access to Methadone in Correctional Facilities and Save Lives.; 2022. Accessed February 25, 2024. https:\/\/americanhealth.jhu.edu\/sites\/default\/files\/JHU-026%20Methadone%20White%20Paper-r1.pdf"},{"issue":"10","key":"9635_CR36","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/jhm.13176","volume":"18","author":"LA Haber","year":"2023","unstructured":"Haber LA, Nguyen OK, Taub J, Martin M. Policy in clinical practice: Elimination of the buprenorphine \"X-waiver\". J Hosp Med. 2023;18(10):931-933. https:\/\/doi.org\/10.1002\/jhm.13176.","journal-title":"J Hosp Med."},{"key":"9635_CR37","doi-asserted-by":"publisher","unstructured":"Evans EA, Pivovarova E, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail. J Subst Abuse Treat. 2022;138. https:\/\/doi.org\/10.1016\/j.jsat.2022.108746","DOI":"10.1016\/j.jsat.2022.108746"},{"issue":"3","key":"9635_CR38","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/jhm.13223","volume":"19","author":"LA Haber","year":"2024","unstructured":"Haber LA, Kaiksow FA, Williams BA, Crane JT. Hospital care while incarcerated: A tale of two policies. J Hosp Med. 2024;19(3):230-234. https:\/\/doi.org\/10.1002\/jhm.13223.","journal-title":"J Hosp Med."},{"issue":"10","key":"9635_CR39","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1007\/s11606-024-08842-3","volume":"39","author":"LA Haber","year":"2024","unstructured":"Haber LA, Sears D, Williams BA. Medicaid for Medical-Correctional Care: Time to Manage What is Reimbursed. J Gen Intern Med. 2024;39(10):1910-1913. https:\/\/doi.org\/10.1007\/s11606-024-08842-3.","journal-title":"J Gen Intern Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09635-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09635-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09635-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T22:02:16Z","timestamp":1780005736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09635-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":39,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["9635"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09635-y","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}